1249 related articles for article (PubMed ID: 22078877)
1. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.
Cordenonsi M; Zanconato F; Azzolin L; Forcato M; Rosato A; Frasson C; Inui M; Montagner M; Parenti AR; Poletti A; Daidone MG; Dupont S; Basso G; Bicciato S; Piccolo S
Cell; 2011 Nov; 147(4):759-72. PubMed ID: 22078877
[TBL] [Abstract][Full Text] [Related]
2. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
3. Hippo pathway and breast cancer stem cells.
Maugeri-Saccà M; De Maria R
Crit Rev Oncol Hematol; 2016 Mar; 99():115-22. PubMed ID: 26725175
[TBL] [Abstract][Full Text] [Related]
4. VEGF-neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin.
Elaimy AL; Guru S; Chang C; Ou J; Amante JJ; Zhu LJ; Goel HL; Mercurio AM
Sci Signal; 2018 May; 11(528):. PubMed ID: 29717062
[TBL] [Abstract][Full Text] [Related]
5. SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis.
Zhu Q; Le Scolan E; Jahchan N; Ji X; Xu A; Luo K
Dev Cell; 2016 Jun; 37(5):399-412. PubMed ID: 27237790
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TAZ domains important for the induction of breast cancer stem cell properties and tumorigenesis.
Li YW; Shen H; Frangou C; Yang N; Guo J; Xu B; Bshara W; Shepherd L; Zhu Q; Wang J; Hu Q; Liu S; Morrison CD; Sun P; Zhang J
Cell Cycle; 2015; 14(1):146-56. PubMed ID: 25602524
[TBL] [Abstract][Full Text] [Related]
7. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
8. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the Hippo signaling pathway.
Nandy SB; Arumugam A; Subramani R; Pedroza D; Hernandez K; Saltzstein E; Lakshmanaswamy R
Oncotarget; 2015 Jul; 6(19):17366-78. PubMed ID: 25962054
[TBL] [Abstract][Full Text] [Related]
10. The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park JH; Shin JE; Park HW
Mol Cells; 2018 Feb; 41(2):83-92. PubMed ID: 29429151
[TBL] [Abstract][Full Text] [Related]
11. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
[TBL] [Abstract][Full Text] [Related]
12. TAZ Controls
Tiffon C; Giraud J; Molina-Castro SE; Peru S; Seeneevassen L; Sifré E; Staedel C; Bessède E; Dubus P; Mégraud F; Lehours P; Martin OCB; Varon C
Cells; 2020 Jun; 9(6):. PubMed ID: 32545795
[No Abstract] [Full Text] [Related]
13. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.
Takebe N; Warren RQ; Ivy SP
Breast Cancer Res; 2011 Jun; 13(3):211. PubMed ID: 21672282
[TBL] [Abstract][Full Text] [Related]
14. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
[TBL] [Abstract][Full Text] [Related]
16. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.
Maugeri-Saccà M; Barba M; Pizzuti L; Vici P; Di Lauro L; Dattilo R; Vitale I; Bartucci M; Mottolese M; De Maria R
Expert Rev Mol Med; 2015 Jul; 17():e14. PubMed ID: 26136233
[TBL] [Abstract][Full Text] [Related]
17. A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells.
Chang C; Goel HL; Gao H; Pursell B; Shultz LD; Greiner DL; Ingerpuu S; Patarroyo M; Cao S; Lim E; Mao J; McKee KK; Yurchenco PD; Mercurio AM
Genes Dev; 2015 Jan; 29(1):1-6. PubMed ID: 25561492
[TBL] [Abstract][Full Text] [Related]
18. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
20. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.
Bartucci M; Dattilo R; Moriconi C; Pagliuca A; Mottolese M; Federici G; Benedetto AD; Todaro M; Stassi G; Sperati F; Amabile MI; Pilozzi E; Patrizii M; Biffoni M; Maugeri-Saccà M; Piccolo S; De Maria R
Oncogene; 2015 Feb; 34(6):681-90. PubMed ID: 24531710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
